How to Take an Oncology Drug into the Clinic
The discovery path for new oncology therapeutics is time-consuming and expensive, with figures of around 12 years and between $314M…
Webinars
Discover the latest in clinical development, trials and clinical data management, from our in-house experts. Available on demand, now. Why not also explore our clinical white papers for even more information?
Follow up Discussion : How to Take an Oncology Drug into the Clinic
Following our highly popular webinar, How to Take an Oncology Drug Into the Clinic, Senior Medical Director at Simbec-Orion, Dr Romillie Cruz talked with Professor Sarah Blagden, Professor of Medical Oncology, at the University of Oxford about some of the topics raised during the presentation. Role of the ECMC (…
Two-part webinar series: Navigating the Regulatory Journey From Nonclinical To Early Phase Clinical Trials
Now available on demand Being first to market with an innovator drug remains the ultimate goal for all and most…
Embedding Neuroscience Techniques to Measure Target Engagement in First-In-Human CNS Clinical Trials
Clinical trials for central nervous system (CNS) conditions have historically been notoriously difficult for a myriad of reasons with a failure rate…
Utilising a Virtual Central Laboratory Approach to Balance the Delivery, Budget and Risk for Clinical Trials
Decentralisation has been one of the biggest outcomes of the COVID-19 pandemic. The speed and degree to which traditional healthcare…
Precision Oncology: An Era that Calls for a New Model for Conducting Clinical Trials?
Genomic sequencing techniques and bioinformatics have led us to a better understanding of cancer biology, resulting in a shift from…
Accelerate Early Clinical Development with Adaptive, Multi-Part, First-in-Human Study Design
In early clinical development, making changes to a study design after regulatory approval can cause significant delays. These can be avoided…
Meeting the Needs of Rare Disease Patients in Clinical Trials During the COVID-19 Pandemic
A Discussion on Regulatory and Operational Considerations This 1-hour webinar discusses how the COVID-19 pandemic has impacted clinical studies for…
Time for a Clinical Trials Revolution – Complex Innovative Design (CID) Cancer Trials
This 1-hour webinar reviews a published consensus statement from the British Journal of Cancer (BJC), looking at recommendations for effective…
Phase I Studies in Patient Populations:De-risking Clinical Development by Obtaining Key Patient Data Earlier
In this webinar members of our specialist, early phase Project Management team discuss how they tackled the range of challenges…
Rare Disease & Orphan Drug Development - Cost-efficient trial design to minimise cash burn
Discussion topics include: Key challenges to improve cost-efficiency in clinical development of orphan drugs Regulatory evolution in the review process…
Effective Implementation of the Revised EMA First-into-Human (FiH) Guidance to Accelerate Your Early Clinical Development
In this webinar the speakers discuss the use of integrated protocols (umbrella protocols) to maximise programme efficiency. Attendees will learn how…
Scintigraphy: Providing Critical Data in Early Clinical Development
If you are embarking on your clinical development plan, consider a non-invasive in vivo evaluation of drug delivery systems. Scintigraphy gives you the…